|
SPIN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.93421999999943E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.233400E-04 |
| Normal-vs-Stage2 |
7.180700E-03 |
| Normal-vs-Stage3 |
1.36350000001784E-06 |
| Normal-vs-Stage4 |
3.86179999978253E-07 |
| Stage1-vs-Stage2 |
8.664800E-01 |
| Stage1-vs-Stage3 |
2.353600E-02 |
| Stage1-vs-Stage4 |
9.736200E-03 |
| Stage2-vs-Stage3 |
1.816620E-01 |
| Stage2-vs-Stage4 |
6.342100E-02 |
| Stage3-vs-Stage4 |
4.237000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.84239999999614E-05 |
| Normal-vs-AfricanAmerican |
4.728200E-02 |
| Normal-vs-Asian |
2.758500E-03 |
| Caucasian-vs-AfricanAmerican |
5.096400E-01 |
| Caucasian-vs-Asian |
5.857200E-01 |
| AfricanAmerican-vs-Asian |
8.204200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.93570000004162E-06 |
| Normal-vs-Female |
8.07590000000413E-05 |
| Male-vs-Female |
3.386800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.436920E-03 |
| Normal-vs-Age(41-60Yrs) |
5.76599999999594E-05 |
| Normal-vs-Age(61-80Yrs) |
9.42620000055072E-07 |
| Normal-vs-Age(81-100Yrs) |
6.417300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.003200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.665790E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.836550E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.889410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.687400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.664800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.243500E-03 |
| Classical-VS-Follicular |
2.431600E-01 |
| Classical-VS-Other |
8.374000E-01 |
| Classical-VS-Normal |
5.639000E-04 |
| Tall-VS-Follicular |
5.335600E-02 |
| Tall-VS-Other |
1.883640E-01 |
| Tall-VS-Normal |
2.51230000003488E-06 |
| Follicular-VS-Other |
8.642400E-01 |
| Follicular-VS-Normal |
5.197300E-04 |
| Other-VS-Normal |
1.250580E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.03489999999596E-05 |
| Normal-vs-N1 |
9.63170000000124E-05 |
| N0-vs-N1 |
5.109000E-01 |
|
|
